CTAK Booth Talk and Demo at ASCRS 2024
May 22, 2024
Drs. Peter Hersh, Steven Greenstein and William Wiley present the latest data on CTAK and walk through surgical cases using the latest innovation for keratoconus.
Recent Articles
-
Bernie’s Quarterly Update – November 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
Bernie’s Quarterly Update – July 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...
READ MORE
CTAK Demonstration at ASCRS 2023
August 14, 2023
In this recording of the live presentation from ASCRS 2023, Peter S. Hersh, M.D.; Steven A. Greenstein, M.D.; and John P. Berdahl, M.D. showcase CorneaGen’s newest addition to their Sterile Tissue offerings, Corneal Tissue Addition for Keratoplasty (CTAK). CTAK offers an innovative solution for keratoconic eyes with advanced corneal contouring using patient-specific laser-cut tissue segments. These tissue are gamma-irradiated for sterility and stability, providing enhanced vision, comfort, and the opportunity to regain sight while honoring the gift of donation.
Recent Articles
-
Bernie’s Quarterly Update – November 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
Bernie’s Quarterly Update – July 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...
READ MORE
Surgical Video of Corneal Tissue Addition For Keratoconus (CTAK)
November 7, 2023
Corneal Tissue Addition for Keratoplasty or CTAK is an innovative option for corneal contouring of keratoconic eyes. This video will show the procedure from beginning to end. CTAK is a form of a lamellar keratoplasty where a custom designed femtosecond created corneal stromal insert is placed into corneal stromal channels. The surgical plan is carefully designed and customized for each patient eye. CTAK technology is made possible by the collaboration of Peter S. Hersh, M.D., Steven A. Greenstein, M.D. and CorneaGen.
Recent Articles
-
Bernie’s Quarterly Update – November 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
Bernie’s Quarterly Update – July 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...
READ MORE